DTX3L is reported to regulate the ubiquitin modification of PARP family proteins (PARP1, PARP2, PARP9, PARP14), promoting proliferation, migration and chemotherapy resistance of lymphoma, glioma, and melanoma (16). The gene discussed is PARP1; the disease is melanoma.